We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
-0.65%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.1B
AUM Growth
-$3.55B
Cap. Flow
-$2.96B
Cap. Flow %
-10.53%
Top 10 Hldgs %
16.2%
Holding
597
New
82
Increased
154
Reduced
208
Closed
58

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$321M
2
TSLA icon
Tesla
TSLA
+$273M
3
MSFT icon
Microsoft
MSFT
+$159M
4
EVR icon
Evercore
EVR
+$157M
5
ETN icon
Eaton
ETN
+$152M

Sector Composition

Rank Sector Weight
1 Technology 22.47%
2 Financials 14.79%
3 Healthcare 13.99%
4 Industrials 12.34%
5 Consumer Discretionary 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPG icon
151
TPG
TPG
$6.85B
$47.4M 0.17%
1,000,372
-193,826
-16% -$11.3M
BBY icon
152
Best Buy
BBY
$18.5B
$47M 0.17%
637,832
-182,973
-22% -$15.1M
KVYO icon
153
Klaviyo
KVYO
$5.49B
$46.5M 0.17%
1,538,220
+790,146
+106% +$31.9M
LOAR icon
154
Loar Holdings
LOAR
$6.39B
$46.3M 0.17%
655,686
-154,817
-19% -$11.2M
FANG icon
155
Diamondback Energy
FANG
$56.2B
$46.2M 0.16%
288,815
-28,332
-9% -$4.57M
DSGX icon
156
Descartes Systems
DSGX
$6.39B
$46.1M 0.16%
457,697
-200,015
-30% -$22.1M
SAIA icon
157
Saia
SAIA
$9.33B
$45.5M 0.16%
130,131
+16,634
+15% +$7.24M
ADMA icon
158
ADMA Biologics
ADMA
$2.01B
$44.5M 0.16%
2,241,623
+34,346
+2% +$594K
PRMB
159
Primo Brands
PRMB
$8.26B
$44.4M 0.16%
1,251,670
+232,331
+23% +$7.59M
PLD icon
160
Prologis
PLD
$136B
$44.2M 0.16%
395,412
-12,345
-3% -$1.43M
QTWO icon
161
Q2 Holdings
QTWO
$3.7B
$44.2M 0.16%
552,399
+4,181
+0.8% +$369K
ACLX
162
DELISTED
Arcellx
ACLX
$43.6M 0.16%
664,526
-310,306
-32% -$21M
KMPR icon
163
Kemper
KMPR
$1.71B
$43.6M 0.16%
652,005
-33,003
-5% -$2.19M
DKS icon
164
Dick's Sporting Goods
DKS
$17.9B
$43M 0.15%
+213,555
New +$47.7M
TEVA icon
165
Teva Pharmaceuticals
TEVA
$41.2B
$42.6M 0.15%
2,770,120
+365,225
+15% +$6.52M
GMED icon
166
Globus Medical
GMED
$10.9B
$42.4M 0.15%
579,861
-115,815
-17% -$9.57M
LFUS icon
167
Littelfuse
LFUS
$11.2B
$42.1M 0.15%
214,202
+16,661
+8% +$3.81M
CWAN
168
DELISTED
Clearwater Analytics
CWAN
$41.8M 0.15%
1,561,249
+750,590
+93% +$21.1M
SFM icon
169
Sprouts Farmers Market
SFM
$8.17B
$41.6M 0.15%
272,776
+36,396
+15% +$5.43M
BDX icon
170
Becton Dickinson
BDX
$45.6B
$41.4M 0.15%
180,948
+13,687
+8% +$3.18M
HD icon
171
Home Depot
HD
$332B
$41.3M 0.15%
112,713
-35
-0% -$13.6K
BA.PRA
172
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$7.86B
0
CVSA
173
Covista Inc
CVSA
$4.3B
$40.8M 0.15%
+405,693
New +$40.5M
GH icon
174
Guardant Health
GH
$20.2B
$40.7M 0.14%
+954,493
New +$41.2M
MRC
175
DELISTED
MRC Global
MRC
$40.2M 0.14%
3,498,499
+2,696,044
+336% +$34.8M

Similar funds

Lord, Abbett & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Lord, Abbett & Co held 597 positions worth $28.1B, down 11% from $31.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Lord, Abbett & Co withdrew a net $2.96B in Q1 2025, closing 58 positions and reducing 208 holdings. Its most notable exit was Tesla, an estimated $273M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lord, Abbett & Co opened a new position in Gilead Sciences worth $167M.

  • Lord, Abbett & Co's largest Q1 2025 buy was Gilead Sciences: 1,491,377 shares worth $167M.
  • Lord, Abbett & Co added most to Meta Platforms (Facebook) in Q1 2025, an estimated $210M increase.
  • Lord, Abbett & Co's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $321M.
  • Lord, Abbett & Co fully exited Tesla in Q1 2025, selling an estimated $273M.
  • Lord, Abbett & Co's ten largest holdings make up 16% of its $28.1B portfolio in Q1 2025.
  • Lord, Abbett & Co opened 82 new positions and closed 58 in Q1 2025.
  • Lord, Abbett & Co's portfolio value fell 11% quarter-over-quarter to $28.1B.

Based on Lord, Abbett & Co's 13F filing for Q1 2025, filed 13 May 2025.